Cargando…

Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice

Acute liver injury (ALI) is a severe syndrome and can further develop into acute liver failure (ALF) which can lead to high mortality and cause irreversible liver injuries in the clinic. Liver transplantation is the most common treatment; however, liver donors are lacking, and the progression of ALF...

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Wenwen, Wang, Qi, Jia, Mingxia, Dong, Sijia, Li, Sijie, Yang, Jie, Liu, Guoyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102161/
https://www.ncbi.nlm.nih.gov/pubmed/35563293
http://dx.doi.org/10.3390/ijms23094903
_version_ 1784707264147357696
author Mu, Wenwen
Wang, Qi
Jia, Mingxia
Dong, Sijia
Li, Sijie
Yang, Jie
Liu, Guoyun
author_facet Mu, Wenwen
Wang, Qi
Jia, Mingxia
Dong, Sijia
Li, Sijie
Yang, Jie
Liu, Guoyun
author_sort Mu, Wenwen
collection PubMed
description Acute liver injury (ALI) is a severe syndrome and can further develop into acute liver failure (ALF) which can lead to high mortality and cause irreversible liver injuries in the clinic. Liver transplantation is the most common treatment; however, liver donors are lacking, and the progression of ALF is rapid. Nanoparticles can increase the bioavailability and the targeted accumulation of drugs in the liver, so as to significantly improve the therapeutic effect of ALI. Curcumin derivative COP-22 exhibits low cytotoxicity and effective anti-inflammatory activity; however, it has poor water solubility. In this study, COP-22-loaded bovine serum albumin (BSA) nanoparticles (22 NPs) were prepared and characterized. They exhibit effective hepatoprotective effects by inhibiting inflammation, oxidative stress, and apoptosis on Lipopolysaccharide/D-Galactosamine-induced acute liver injury of mice. The anti-inflammatory activity of 22 NPs is related to the regulation of the NF-κB signaling pathways; the antioxidant activity is related to the regulation of the Nrf2 signaling pathways; and the apoptosis activity is related to mitochondrial pathways, involving Bcl-2 family and Caspase-3 protein. These three cellular pathways are interrelated and affected each other. Moreover, 22 NPs could be passively targeted to accumulate in the liver through the retention effect and are more easily absorbed than 22.HCl salt in the liver.
format Online
Article
Text
id pubmed-9102161
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91021612022-05-14 Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice Mu, Wenwen Wang, Qi Jia, Mingxia Dong, Sijia Li, Sijie Yang, Jie Liu, Guoyun Int J Mol Sci Article Acute liver injury (ALI) is a severe syndrome and can further develop into acute liver failure (ALF) which can lead to high mortality and cause irreversible liver injuries in the clinic. Liver transplantation is the most common treatment; however, liver donors are lacking, and the progression of ALF is rapid. Nanoparticles can increase the bioavailability and the targeted accumulation of drugs in the liver, so as to significantly improve the therapeutic effect of ALI. Curcumin derivative COP-22 exhibits low cytotoxicity and effective anti-inflammatory activity; however, it has poor water solubility. In this study, COP-22-loaded bovine serum albumin (BSA) nanoparticles (22 NPs) were prepared and characterized. They exhibit effective hepatoprotective effects by inhibiting inflammation, oxidative stress, and apoptosis on Lipopolysaccharide/D-Galactosamine-induced acute liver injury of mice. The anti-inflammatory activity of 22 NPs is related to the regulation of the NF-κB signaling pathways; the antioxidant activity is related to the regulation of the Nrf2 signaling pathways; and the apoptosis activity is related to mitochondrial pathways, involving Bcl-2 family and Caspase-3 protein. These three cellular pathways are interrelated and affected each other. Moreover, 22 NPs could be passively targeted to accumulate in the liver through the retention effect and are more easily absorbed than 22.HCl salt in the liver. MDPI 2022-04-28 /pmc/articles/PMC9102161/ /pubmed/35563293 http://dx.doi.org/10.3390/ijms23094903 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mu, Wenwen
Wang, Qi
Jia, Mingxia
Dong, Sijia
Li, Sijie
Yang, Jie
Liu, Guoyun
Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice
title Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice
title_full Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice
title_fullStr Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice
title_full_unstemmed Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice
title_short Hepatoprotective Effects of Albumin-Encapsulated Nanoparticles of a Curcumin Derivative COP-22 against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Injury in Mice
title_sort hepatoprotective effects of albumin-encapsulated nanoparticles of a curcumin derivative cop-22 against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102161/
https://www.ncbi.nlm.nih.gov/pubmed/35563293
http://dx.doi.org/10.3390/ijms23094903
work_keys_str_mv AT muwenwen hepatoprotectiveeffectsofalbuminencapsulatednanoparticlesofacurcuminderivativecop22againstlipopolysaccharidedgalactosamineinducedacuteliverinjuryinmice
AT wangqi hepatoprotectiveeffectsofalbuminencapsulatednanoparticlesofacurcuminderivativecop22againstlipopolysaccharidedgalactosamineinducedacuteliverinjuryinmice
AT jiamingxia hepatoprotectiveeffectsofalbuminencapsulatednanoparticlesofacurcuminderivativecop22againstlipopolysaccharidedgalactosamineinducedacuteliverinjuryinmice
AT dongsijia hepatoprotectiveeffectsofalbuminencapsulatednanoparticlesofacurcuminderivativecop22againstlipopolysaccharidedgalactosamineinducedacuteliverinjuryinmice
AT lisijie hepatoprotectiveeffectsofalbuminencapsulatednanoparticlesofacurcuminderivativecop22againstlipopolysaccharidedgalactosamineinducedacuteliverinjuryinmice
AT yangjie hepatoprotectiveeffectsofalbuminencapsulatednanoparticlesofacurcuminderivativecop22againstlipopolysaccharidedgalactosamineinducedacuteliverinjuryinmice
AT liuguoyun hepatoprotectiveeffectsofalbuminencapsulatednanoparticlesofacurcuminderivativecop22againstlipopolysaccharidedgalactosamineinducedacuteliverinjuryinmice